Increased serum levels of nitric oxide metabolites among users: A possible role in progestin-induced bleeding

Human Reproduction

Volumn 20, Issue 1, 2005, Pages 302-306

  Shaamash, A H ^a   Zakhari, M M ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Abnormal bleeding; Progestin only contraceptive; Serum NO metabolites

Indexed keywords

CADMIUM; LEVONORGESTREL; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHEMICAL REACTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DRUG IMPLANT; DRUG USE; ENDOMETRIUM; FEMALE; FEMALE FERTILITY; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; MENSTRUATION; OXIDATION; QUANTITATIVE ANALYSIS; SPOTTING; UTERUS BLEEDING; UTERUS FUNCTION; VASCULAR ENDOTHELIUM;

EID: 12444288589     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh541     Document Type: Article

References (37)

1. Blumenthal RD, Taylor AP, Goldman L, Brown G and Goldenberg DM (2002) Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium. Fertil Steril 78,294-300.
2. Chwalisz K and Garfield RE (2000) Role of nitric oxide in implantation and menstruation. Hum Reprod 15,96-111.
3. Chwalisz K, Brenner RM, Fuhrmann U and Elger W (1999) Antiproliferative effects of progesterone receptor modulators on the endometrium. In Progesterone, progestins and antiprogestins in the next millennium. Jerusalem, Israel, August 31-September 3 Abstract, p. 55.
4. Ekerhovd E, Enskog A, Caidahl K, Klintland N, Nilsson L, Brännström M and Norström A (2002) Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome. Hum Reprod 16,1334-1339.
5. Faundes A, Sivin I and Stern J (1978) Longacting contraceptive implants. An analysis of menstrual bleeding patterns. Contraception 18,355-365.
6. Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77,527-543.
7. Folkman J and Klagsburn M (1987) Angiogenic factors. Science 235, 442-447.
8. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL and Jain RK (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98,2604-2609.
9. Grasselli F, Basini G, Bussolati S and Tamanini C (2002) Effects of VEGF and bFGF on proliferation and production of steroids and nitric oxide in porcine granulosa cells. Reprod Domest Anim 37,362-368.
10. Hickey M and d'Arcangues C (2002) Vaginal bleeding disturbances and implantable contraceptives. Contraception 65,75-84.
11. Hickey M and Fraser IS (2000) A functional model for progestogen-induced breakthrough bleeding. Hum Reprod 15,1-6.
12. Hickey M and Fraser IS (2002) Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding. Hum Reprod 17,2428-2434.
13. Hickey M, Dwarte D and Fraser IS (1997) The endometrial vascular appearance in Norplant users: preliminary results from a hysteroscopic study. Hum Reprod 11,35-40.
14. Hickey M, Simbar M, Markham R, Russell P and Fraser IS (1999) Changes in endometrial vascular density in Norplant users. Contraception 59, 123-129.
15. Hurskainen R, Teperi J, Paavonon J and Cacciatore B (1999) Menorrhagia and uterine artery blood flow. Hum Reprod 14,186-189.
16. Lau TM, Affandi B and Rogers PA (1999) The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. Mol Hum Reprod 5,57-63.
17. Lebovic DI, Shifren JL, Ryan IP, Mueller MD, Korn AP, Darney PP and Taylor RN (2000) Ovarian steroid and cytokine modulation of human endometrial angiogenesis. Hum Reprod 15,67-77.
18. Lockwood CJ, Schatz F and Krikun G (2004) Angiogenic factors and the endometrium following long term progestin only contraception. Histol Histopathol 19,167-172.
19. Manau D, Balasch J, Jimenez W, Fabregues F, Civico S, Casamitjana R, Creus M and Vanrell JA (2000) Follicular fliud concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response. Hum Reprod 15,1295-1299.
20. McGavigan CJ, Dockery P, Metaxa-Mariatou V, Campbell D, Steward CJ, Cameron II and Campbell S (2003) Hormonally mediated disturbances of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel. Hum Reprod 18,77-84.
21. Meirik O, Fraser IS and d'Arcangues C (2003) Implantable contraceptives for women. Hum Reprod Update 9,1-11.
22. Moncada S and Higgs EA (1993) The L-arginine nitic oxide pathway. N Engl J Med 329,2002-2012.
23. Ota H, Igarashi S, Hatazawa J and Tanaka T (1998) Endothelial nitric oxide synthase in the endomertium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril 69,303-308.
24. Palmer JA, Lau TM, Hickey M, Simbah M and Rogers PA (1996) Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant. Hum Reprod 11,2142-2150.
25. Papapetropoulas A, Garcia-Cardena G, Madri JA and Sessa WC (1997) Nitric oxide production contributes to the angiogenic properties of vascular endometrial growth factor in human endothelial cells. J Clin Invest 100, 3131-3139.
26. Ramsay B, De Belder A, Campbell S, Moncada S and Martin JF (1994) A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. Eur J Clin Invest 74,76-78.
27. Revel A, Barak V, Lavy Y, Anteby E, Abramov Y, Schenker JJ, Amit A, Finci-Yeheskel Z, Mayer M, Simon A et al. (1996) Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyper-stimulation syndrome. Fertil Steril 66,66-71.
28. Shoupe D, Mishell DR Jr, Bopp BL and Fielding M (1991) The significance of bleeding patterns in Norplant users. Obstet Gynecol 77,256-260.
29. Stewart EWA and Nowak PA (1996) Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update 2,295-306.
30. Sun X, Qiu X and Gemzell-Danielsson K (2003) Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase. Fertil Steril 80,1454-1460.
31. Telfer JF, Lyall F, Norman JE and Cameron IT (1995) Identification of nitric oxide synthase in human endometrium. Hum Reprod 10,19-23.
32. Tschugguel W, Schneeberger C, Unfried G, Brautigam G, Stonek F, Wieser F, Vytiska-Binstorfer E, Czerwenka K, Weninger W, Kaider A et al. (1999) Elevation of inducible nitric oxide synthase activity in human during menstruation. Biol Reprod 60,297-304.
33. Van Bezooijen RL, Que I, Ederveen AG, Kloosterboer HJ, Papapoulos SE and Lowik CW (1998) Plasma nitrate + nitrite levels are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats. J Endocrinol 159,27-34.
34. White J, Sullivan M and Patel L (1991) Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring. Contraception 43,401-412.
35. World Health Organization (1992) Special Program of Research Training and Research Development in Reproduction Menstrual Diary (MD) Analysis Program. Geneva, Version 2.3.
36. Zelinski-wooten MB, Slayden OD, Chwalisz K, Stouffer RL and Brenner RM (1998) Chronic treatment of female cycling rhesus monkeys with low doses of the antiprogestin ZK 137-316: establishment of a regimen that permits normal menstrual cyclicity. Hum Reprod 13,259-267.
37. Zervou S, Klentzeris LD and Old RW (1999) Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia. Mol Hum Reprod 5,1048-1054.